Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Tendon Engineering for Comprehensive Advanced Rehabilitation and Enhancement

Project description

New medical device to treat tendon injury

Every year, around 33 million musculoskeletal injuries are reported, with 50 % involving tendon and ligament injuries. Due to their diverse causes, there is no universal solution. The EU-funded TEN4CARE project will address tendon and ligament injuries by developing a medical device made from a 4D nanocomposite fibrous hydrogel, which can be injected minimally invasively to restore tendon integrity. By enhancing cell recruitment and promoting the production of an extracellular matrix, the project seeks to expedite recovery from injuries. Additionally, the project will establish a GMP-validated production process and a regulatory roadmap, providing guidelines for safety, sustainability, and market transfer of its products.

Objective

Every year, around 33 million musculoskeletal injuries are reported, 50% involving tendon and ligament injuries. Due to their diverse aetiology, there is no “one-fits-all” solution. TEN4CARE means a crucial opportunity for the EU Material and MedTech Industries to solve this challenge, by providing a technologically advanced, biomaterial-based medical device that can be applicable in the worst prognostic scenarios, generating a wide impact on the citizens health and wellbeing but also on the sustainability, resilience and business opportunities for the whole industrial sector. We aim to achieve tendon integrity by amplifying the recruitment of cells from surrounding tissues and refining their homing capabilities. This effort will drive the production of extracellular matrix, effectively replacing compromised or absent tissue. The objective is to tackle health complexities linked to tendon and ligament disorders, promoting rapid recovery for acute or chronic conditions. TEN4CARE will develop an innovative strategy for tendon tissue engineering through the design of a medical device based on electromagnetic-responsive shape memory 4D nanocomposite fibrous hydrogel and a minimally invasive surgery to inject and anchor it to bridge tendons/ligaments, able to be implanted using minimally invasive surgery that can be a game changer, as will combine enhanced structural properties, shape memory, antibacterial activity and regenerative capabilities, driven by external forces like magnetic and electric fields. We will get a GMP validated production process, coupled with a scale up, industrially-driven strategy and an early regulatory planning, completed by a regulatory roadmap for the sector and the implied communities; a detailed evaluation of Safety and Sustainability based on SSbD concepts, guiding our developments but also generating general guidelines and discussion for the whole sector and business models and exploitation plans for the transfer of the TEN4CARE products.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-IA - HORIZON Innovation Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-CL4-2024-RESILIENCE-01-TWO-STAGE

See all projects funded under this call

Coordinator

UNIVERSITA DEGLI STUDI DI PAVIA
Net EU contribution
€ 889 462,50
Address
STRADA NUOVA 65
27100 Pavia
Italy
Region
Nord-Ovest Lombardia Pavia
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (15)